
OPCH Stock Forecast & Price Target
OPCH Analyst Ratings
Bulls say
Option Care Health is well-positioned for future growth, with a diverse portfolio of acute and chronic therapies and a distribution network spanning across 43 states. Their recent acquisition and integration with BioScrip has also expanded their reach and capabilities. However, there are potential risks from competition and changes in specialty therapy utilization that could impact their profitability. Further success in their Advanced Practitioner model and consistent positive performance could drive potential upside.
Bears say
Option Care Health is facing a mixed bag in the first quarter and has given lower guidance for 2026 due to lower revenue expectations. Their adjusted EPS and EBITDA remain unchanged, but their cash flow from operations has been reduced. With their share price dropping 24%, this may be seen as a buying opportunity, but with lower revenue and disruptions in the market, it may be difficult for the company to achieve their expected growth in the future.
This aggregate rating is based on analysts' research of Option Care Health and is not a guaranteed prediction by Public.com or investment advice.
OPCH Analyst Forecast & Price Prediction
Start investing in OPCH
Order type
Buy in
Order amount
Est. shares
0 shares